FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Oppenheimer Downgrades Aardvark Therapeutics Inc (AARD) to Perform 'We Await Visibility'
Tweet Send to a Friend
(Updated - October 26, 2026 1:45 PM EDT)
Oppenheimer analyst Leland Gershell downgraded Aardvark Therapeutics Inc (NASDAQ: AARD) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Leland Gershell downgraded Aardvark Therapeutics Inc (NASDAQ: AARD) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
